SOX2 and cancer: In most cases, SOX2 was negative (11/14 cases) or very focally expressed (about 20% of the cancer cells in 3/14 cases), and ALDH1 was, in most cases (11/14 cases), also expressed in at least 20% of the cancer cells (Figure 2A) (see color key).